Abstract
Amphotericin B represents one of the most important drugs available for antifungal therapy especially in the compromised patient. Unfortunately its administration presents many infusion-related or infusion-unrelated adverse effects, which are less frequent (but not absent) in patients receiving lipid-based formulations of amphotericin B. The present paper represents a summary of the prophylactic and therapeutic options available to manage amphotericin B related adverse events.
Translated title of the contribution | Management of amphotericin B-related adverse events |
---|---|
Original language | Italian |
Pages (from-to) | 271-275 |
Number of pages | 5 |
Journal | Giornale Italiano di Malattie Infettive |
Volume | 5 |
Issue number | 5-6 |
Publication status | Published - 1999 |
ASJC Scopus subject areas
- Microbiology (medical)